Research
Research Programs
OBRI operates longitudinal registries collecting real-world data from patients with rheumatoid arthritis and psoriatic arthritis across Ontario.
OBRI Safety and Effectiveness Research Study
Started: 2005
The flagship OBRI study enrolling patients with rheumatoid arthritis in Ontario to collect long-term, real-world data on treatment safety, effectiveness, and health outcomes. Participants are followed at regular intervals to capture information on medications, disease activity, quality of life, and health service utilization.
Study Objectives
- Determine the real-world health effects of different RA therapies, both short- and long-term
- Balance the cost of medications with other health services to identify optimal treatment choices
- Identify which patients respond best to which therapies at different disease stages
- Understand why some patients need to switch therapies over time
Psoriatic Arthritis Registry
Started: 2014
The OBRI Psoriatic Arthritis (PSA) Registry collects long-term real-world data from patients living with psoriatic arthritis. The registry captures information on treatment patterns, disease activity, comorbidities, and patient-reported outcomes to inform clinical decision-making and health policy.
Study Objectives
- Document treatment patterns and outcomes in a real-world psoriatic arthritis population
- Assess long-term safety and effectiveness of biological and conventional therapies
- Identify predictors of treatment response and disease progression
- Support evidence-based drug policy for psoriatic arthritis in Ontario
Who Can Participate
Adults with a confirmed diagnosis of psoriatic arthritis receiving care at a participating rheumatology clinic.
Learn how to get involved →